Sandy Cove Advisors’s CareDx CDNA Stock Holding History

Sandy Cove Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,000	Closed	-$37K	–	117
2022 Q1	$37K	Hold	1,000	–	–	0.03%	229
2021 Q4	$45K	Buy	+1,000	New	+$52.2K	0.04%	201

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Sandy Cove Advisors's CDNA Position: Q2 2022 in Review

Sandy Cove Advisors sold out of CareDx (CDNA) in Q2 2022, closing a stake of 1,000 shares — an estimated $37K sold.

Sandy Cove Advisors first reported a position in CDNA in Q4 2021 and held it in 2 quarters. The position peaked at $45K in Q4 2021. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

Sandy Cove Advisors reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
Sandy Cove Advisors sold 1,000 CareDx shares in Q2 2022, an estimated $37K.
Sandy Cove Advisors first reported a position in CareDx in Q4 2021 and held it in 2 quarters.
Sandy Cove Advisors's CareDx position peaked at $45K in Q4 2021.
184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Sandy Cove Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.